{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:56:20Z","timestamp":1768272980720,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.emc.2022.05.005","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T13:21:19Z","timestamp":1657372879000},"page":"503-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Infectious Pulmonary Diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Rachel","family":"Rafeq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0522-505X","authenticated-orcid":false,"given":"Lauren A.","family":"Igneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.emc.2022.05.005_bib1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.2019.21118","article-title":"Diagnosis and Treatment of Adults with Community-Acquired Pneumonia","volume":"323","author":"Olson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.emc.2022.05.005_bib2","doi-asserted-by":"crossref","first-page":"107663","DOI":"10.1016\/j.pharmthera.2020.107663","article-title":"Updates on community acquired pneumonia management in the ICU","volume":"217","author":"Nair","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.emc.2022.05.005_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12691\/ajmcr-9-1-12","article-title":"Community-Acquired Pneumonia: A Focused Review","volume":"9","author":"Ticona","year":"2021","journal-title":"Am J Med Case Rep"},{"issue":"suppl 2","key":"10.1016\/j.emc.2022.05.005_bib4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.emc.2022.05.005_bib5","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.emc.2022.05.005_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/14787210.2019.1627872","article-title":"Efficacy of Ceftriaxone 1\u00a0g daily Versus 2\u00a0g daily for The Treatment of Community Acquired Pneumonia: A Systematic Review with Meta-Analysis","volume":"17","author":"Telles","year":"2019","journal-title":"Expert Rev Anti-infective Ther"},{"issue":"1","key":"10.1016\/j.emc.2022.05.005_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1186\/s12879-019-4552-8","article-title":"Adult Pneumonia Study Group-Japan. 1g versus 2\u00a0g daily intravenous ceftriaxone in the treatment of community onset pneumonia - a propensity score analysis of data from a Japanese multicenter registry","volume":"19","author":"Hasegawa","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.emc.2022.05.005_bib8","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2165\/00003495-200868130-00004","article-title":"Short- versus long-course antibacterial therapy for community-acquired pneumonia: a meta-analysis","volume":"68","author":"Dimopoulos","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.emc.2022.05.005_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.amjmed.2007.04.023","article-title":"Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis","volume":"120","author":"Li","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.emc.2022.05.005_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00635-18","article-title":"Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults","volume":"62","author":"Tansarli","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.emc.2022.05.005_bib11","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.emc.2022.05.005_bib12","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.emc.2022.05.005_bib13","first-page":"CD006482","article-title":"Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia","volume":"10","author":"Berton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.emc.2022.05.005_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1513\/AnnalsATS.202003-188ST","article-title":"Antibiotic Stewardship in the Intensive Care Unit. An Official American Thoracic Society Workshop Report in Collaboration with the AACN, CHEST, CDC, and SCCM","volume":"17","author":"Wunderink","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.emc.2022.05.005_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/CCM.0000000000002769","article-title":"Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis","volume":"46","author":"Luther","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.emc.2022.05.005_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients - Guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique - SFPT) and the French Society of Anaesthesia","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.emc.2022.05.005_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/phar.2376","volume":"40","author":"Rybak","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"19","key":"10.1016\/j.emc.2022.05.005_bib18","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.emc.2022.05.005_bib19","first-page":"CD007577","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults","volume":"2015","author":"Pugh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.emc.2022.05.005_bib20","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1378\/chest.13-0076","article-title":"Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"144","author":"Dimopoulos","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.emc.2022.05.005_bib21","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"issue":"10167","key":"10.1016\/j.emc.2022.05.005_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.emc.2022.05.005_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-Lactam Allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.emc.2022.05.005_bib24","first-page":"ofw249","article-title":"Using Procalcitonin to Guide Antibiotic Therapy","volume":"7","author":"Rhee","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.emc.2022.05.005_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/CCM.0000000000002953","article-title":"Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies","volume":"46","author":"Lam","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.emc.2022.05.005_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/CCM.0000000000002928","article-title":"Efficacy and safety of procalcitonin guidance in patients with suspected or confirmed sepsis: a systematic review and meta-analysis","volume":"46","author":"Iankova","year":"2018","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.emc.2022.05.005_bib27","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.emc.2022.05.005_bib28","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/phar.2188","article-title":"Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature","volume":"38","author":"Carr","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.emc.2022.05.005_bib29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/cid\/ciz974","article-title":"Determining the Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Antimicrobial Stewardship","volume":"71","author":"Mergenhagen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.emc.2022.05.005_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciy024","article-title":"The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis With Antimicrobial Stewardship Implications","volume":"67","author":"Parente","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.emc.2022.05.005_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/10600280211023209","article-title":"Impact of Prior-to-Admission Methicillin-Resistant Staphylococcus aureus Nares Screening in Critically Ill Adults With Pneumonia","volume":"56","author":"Mallidi","year":"2022","journal-title":"Ann Pharmacother"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862722000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862722000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:38:54Z","timestamp":1760006334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862722000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0733862722000323"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2022.05.005","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious Pulmonary Diseases","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2022.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}